Rev. Date: 03-Aug-12 Art: 716675-00L CK-MB - 7
References
1. Braunwald, E, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina
and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/
American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients
with Unstable Angina). J Am Coll Cardiol 2002, 40: 1366-1374.
2. D.W. Moss, A.R. Henderson, “Enzymes” in Tietz Textbook of Clinical Chemistry – Second Edition, C.A.
Burtis and E.R. Ashwood, eds. (Philadelphia: W.B. Saunders Company, 1994).
3. Apple FS, Murakami MA. Cardiac Troponin and Creatine Kinase MB Monitoring during In-Hospital
Myocardial Reinfarction, Clin Chem 2005, 51(2): 460-463.
4. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for
the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. J
Am Coll Cardiol 2000, 36: 970-1062.
5. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction
defined – a consensus document of the joint European Society of Cardiology/American College of
Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36: 959-969.
6. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, et al. It’s time for a change to a troponin
standard. Circulation 2000, 102: 1216-1220.
7. Newby LK, Alpert JS, Ohman EM, Thygesen K, Califf RM. Changing the diagnosis of acute myocardial
infarction: implications for practice and clinical investigations. Am Heart J 2002, 144: 957-980.
8. Apple FS, Sharkey SW, Falahati A, Murakami MA, Mitha N, Christensen D. Assessment of left ventricular
function using serum cardiac troponin I measurements following myocardial infarction. Clinica Chimica Acta
1998, 272: 59-67.
9. A.S. Maisel, “Point-of-Care Diagnosis and Management of Myocardial Infarction and Congestive Heart
Failure” in Principles & Practice of Point-of-Care Testing, G.J. Kost, ed. (Philadelphia: Lippincott Williams &
Wilkins, 2002).
10. Clinical and Laboratory Standards Institute (CLSI). Method Comparison and Bias Estimation Using Patient
Samples; Approved Guideline – Second Edition. CLSI document EP9-A2 [ISBN 1-56238-472-4]. Clinical
and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898,
USA 2002.
11. P.J. Cornbleet and N. Gochman, “Incorrect Least-Squares Regression Coefficients in Method-Comparison
Analysis,” Clinical Chemistry 25:3, 432 (1979).
12. Clinical and Laboratory Standards Institute (CLSI) Interference Testing in Clinical Chemistry; Approved
Guideline. CLSI document EP7-A [ISBN 1-56238-480-5]. Clinical and Laboratory Standards Institute, 940
West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA 2002.
13. Clinical and Laboratory Standards Institute (CLSI). Immunoassay Interference by Endogenous Antibodies;
Proposed Guidelines. CLSI document I/LA30-P (ISBN 1-56238-633-6) Clinical and Laboratory Standards
Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2007.
14. Bjerner et al. Immunometric Assay Interference: Incidence and Prevention. Clin. Chem. 2002; 48:613.
15. Kricka, Interferences in Immunoassays - Still a Threat. Clin. Chem. 2000; 46:1037.
16. Schroff et al. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
Cancer Res. 1985; 45:879.
17. Primus et al. “Sandwich”-type immunoassay of carcinoembryonic antigen in patients receiving murine
monoclonal antibodies for diagnosis and therapy. Clin. Chem. 1988; 34-261.
18. Nahm et al. Heteroantibody: phantom of the immunoassay. Clin. Chem. 1990; 36:829.
19. Boscato et al. Heterophilic antibodies: a problem for all immunoassays. Clin Chem. 1988; 34:27.
i-STAT is a registered trademark of the Abbott Group of Companies in various jurisdictions.
To Next Page
Loading...
